Results 91 to 100 of about 14,309 (181)

Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521]. [PDF]

Int J Infect Dis, 2021
Pandit A, Bhalani N, Bhushan BLS, Koradia P, Gargiya S, Bhomia V, Kansagra K.   +6 more
europepmc   +1 more source

Interferon Alfa-N1 [PDF]

, 2020
openaire   +1 more source

Comment on: Efficacy and safety of posterior subtenon interferon alfa-2B injection in recurrent inflammatory macular edema. [PDF]

Indian J Ophthalmol
Sahare H, Anupama H.
europepmc   +1 more source

Intralesional Interferon Alfa-2b Versus Cryotherapy for Common Warts on the Hands and Feet: A Randomized, Open-Label, Controlled Trial. [PDF]

J Cosmet Dermatol
Jin Y, Shen X.
europepmc   +1 more source

Interferon Alfa-N3 [PDF]

, 2020
openaire   +1 more source

Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study. [PDF]

JHEP Rep
Schwarz M, Hintersteininger M, Schwarz C, Panzer M, Pfisterer N, Loschko N, Hartl L, Dorn L, Laferl H, Trauner M, Stättermayer AF, Mandorfer M, Graziadei I, Maieron A, Moschen A, Aigner E, Stadlbauer V, Madl C, Aberle SW, Zoller H, Gschwantler M, Reiberger T, Jachs M.   +22 more
europepmc   +1 more source

Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance). [PDF]

Cancer Immunol Res
Liu A, Johnson C, Niedzwiecki D, Relation T, Yarlagadda SV, Gajewski TF, Carson WE.   +6 more
europepmc   +1 more source

Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b. [PDF]

Rom J Ophthalmol, 2020
Rocha-de-Lossada C, Alba-Linero C, Borroni D, Rachwani-Anil R, Zamorano-Martín F, Rodríguez-Calvo-de-Mora M.   +5 more
europepmc   +1 more source

Recombinant Interferon Alfa [PDF]

, 2020
openaire   +1 more source